Dr Claire Dyson
Dr Claire Dyson, Director of Medical Devices, Head of Notified Body MDR and IVDR, NSAI
Dr Claire Dyson is Director of Medical Devices at the National Standards Authority of Ireland (NSAI), where she provides strategic leadership for the organisation’s medical devices division and its role as a Notified Body under EU MDR and IVDR. She joined NSAI in June 2025, bringing extensive experience across the full medical device lifecycle, from early‑stage innovation through to regulatory approval and global market access.
Claire is a recognised medical device regulatory expert with deep expertise in conformity assessment, certification bodies, and quality management systems, including ISO 13485, MDSAP, CE, and UKCA requirements. Her career spans scientific research, product development, and senior leadership roles within internationally recognised certification organisations, giving her a comprehensive, end‑to‑end understanding of regulatory systems from concept to commercialisation.
Prior to joining NSAI, Claire held senior leadership positions within DQS and DEKRA, where she was responsible for the UK medical devices business. Her remit included P&L ownership, organisational leadership, and the delivery of regulatory certification services. During this period, she led the implementation of the UKCA designation project and contributed to the development of a global medical device certification model, supporting the evolution of internationally integrated assurance services.
Claire entered the certification and conformity assessment sector in 2018, following an early career in rational drug design and pharmaceutical research. She transitioned into medical devices through technologies combining devices with drugs and drug‑delivery systems, providing a strong scientific foundation for her subsequent regulatory work. She has worked closely with regulators and industry stakeholders across the EU, UK, and international markets, supporting manufacturers in navigating complex regulatory pathways and market transitions.
Claire holds a degree in Biochemistry with Biotechnology from the University of St Andrews and a PhD in rational drug design from the University of Leicester, supported by the Wellcome Trust. She is known for her collaborative and inclusive leadership style, strong commitment to public health, and focus on building capable, high‑performing teams while upholding the highest standards of regulatory integrity and patient safety.